Preprint · CC-BY
via OpenAlex
Fisetin alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis by inhibiting Src activation to block macrophage-myofibroblast transition
Yonghong Jian, Rong Li, Yuhan Wan, Wei Li, Ke Su, Yifei Yang
Research Square · 2025
Altered intercellular communication
Chronic inflammation
Senolytics
Cell culture / in vitro
Mouse
In vitro
Abstract
Abstract Fisetin, as a natural dietary flavonoid, exhibits multiple biological activities such as anti-inflammatory, anti-oxidant, and anti-tumorigenic activities. Previous studies have indicated that fisetin has potential renal protective effects in many animal models of kidney disease. However, the effect of fisetin on unilateral ureteral obstruction (UUO)-induced renal interstitial fibrosis (RIF) remains largely unknown. In our present study, we found that fisetin attenuated UUO-induced kidney injury by decreasing fibrotic lesion and the accumulation of extracellular matrix (ECM). The results showed that fisetin could effectively block macrophage-to-myofibroblast transition (MMT) in the kidneys of UUO mice in vivo and in transforming growth factor-β1(TGFb1)-stimulated bone marrow-derived macrophages (BMDM) in vitro. Molecular docking was employed to explore the interactions between fisetin and Src (a key mediator in MMT). The results indicated that fisetin could form hydrogen bonds and hydrophobic interactions with Src, thus binding effectively in the active pocket of Src and exhibiting strong affinity. Further in vivo and in vitro investigation demonstrated that fisetin inhibited activity of Src and subsequently lowered the phosphorylation levels of epidermal growth factor receptor (EGFR) at Tyr845, ERK1/2 and Smad3. In conclusion, this study revealed the mechanism by which fisetin blocked the progression of MMT by inhibiting the activationof Src, thus alleviating UUO-induced RIF. Therefore, fisetin might be a potential therapeutic agent for preventing and alleviating renal fibrosis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.21203/rs.3.rs-7548347/v1
- Canonical
- link ↗
- Fetched
- 2026-11-02 MST
Cite this
APA
Jian, Y., Li, R., Wan, Y., Li, W., Su, K., & Yang, Y. (2025). Fisetin alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis by inhibiting Src activation to block macrophage-myofibroblast transition. <em>Research Square</em>. https://doi.org/10.21203/rs.3.rs-7548347/v1
Vancouver
Jian Y, Li R, Wan Y, Li W, Su K, Yang Y. Fisetin alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis by inhibiting Src activation to block macrophage-myofibroblast transition. Research Square. 2025. doi:10.21203/rs.3.rs-7548347/v1.
BibTeX
@unpublished{yonghong2025Fiseti,
title = {Fisetin alleviates unilateral ureteral obstruction-induced renal interstitial fibrosis by inhibiting Src activation to block macrophage-myofibroblast transition},
author = {Yonghong Jian and Rong Li and Yuhan Wan and Wei Li and Ke Su and Yifei Yang},
journal = {Research Square},
year = {2025},
doi = {10.21203/rs.3.rs-7548347/v1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pharmacognosy Magazine 2015
Preprint · CC-BY
Anti-aging effect of polysaccharide from Bletilla striata on nematode Caenorhabditis elegans
Oxidative Medicine and Cellular Longevity 2015
Open access · CC-BY
Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans
BioMed Research International 2014
Open access · CC-BY
Resveratrol as a Therapeutic Agent for Alzheimer’s Disease
Gerontology 2014
Citation only
Molecular Basis of the ‘Anti-Aging' Effect of Spermidine and Other Natural Polyamines - A Mini-Review
BMC complementary medicine and therapies 2025
Open access · OA
Identification of active anti-aging ingredients from asparagus cochinchinensis based on the spectrum-effect relationship.
British Journal of Pharmacology 2011
Open access · OA